The QualityStocks Daily Thursday, June 7th, 2018

Today's Top 3 Investment Newsletters

TraderPower (TOPS) +47.50%

StockMarketWatch (AVHI) +28.79%

Trading Concepts (CONN) +24.56%

The QualityStocks Daily Stock List

EnviroLeach Technologies, Inc. (EVLLF)

MarketWatch, Stockhouse, GuruFocus, 4-Traders, OTC Markets, Barchart, Investopedia, Investors Hub, Dividend Investor, Marketwired, Streetwise Reports and Stock Market Revolution reported on EnviroLeach Technologies, Inc. (EVLLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, EnviroLeach Technologies, Inc. is a technology enterprise and near-term gold producer. It engages in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and E-Waste sectors. The Company’s goal is to become a top gold producer via the “Urban-Mining” of end-of-life electronics and be a major player in the extraction of precious metals in the traditional mining space. Established in 2016, EnviroLeach Technologies is headquartered in Burnaby, British Columbia.

Employing its proprietary non-cyanide, non-acid based process, the Company extracts precious and base metals from ores, concentrates, and E-Waste using only Food and Drug Administration (FDA) approved additives. EnviroLeach’s strategic global partners include Jabil (JBL), Mineworx Technologies (MWXRF), and Element Six (part of the De Beers Group of Companies).

EnviroLeach Technologies developed an innovative, cost-effective and environmentally-friendly alternative to cyanide and strong-acid based processes now utilized for the extraction of precious metals from mineral ores, concentrates and E-Waste. This process is similar to the standard cyanide vat leaching circuits used today. However, it is much safer and simpler. The patent-pending EnviroLeach formula consists of combining five non-toxic, FDA approved dry ingredients with ambient temperature water.

The oxidizing reagent is the result of selective inorganic electrochemistry that results in the dissolution of the precious metals into an aqueous solution. This is followed by the extraction of the resulting gold complex employing conventional methods such as electrowinning, carbon absorption or precipitation.

The operation is simple. It does not require pressure, elevated temperatures, complex process circuits, intensive gas monitoring or expensive detoxification systems.

In 2017, EnviroLeach Technologies and Mineworx Technologies successfully advanced their proven chemical formulas and mechanical processes with a number of additional proprietary and patent-pending breakthroughs. The new discoveries include major enhancements to the proven EnviroLeach E-Waste process regarding improved leach kinetics, improved recoveries, metal complex stability, element selectivity, metal precipitation and the reusability of the primary solution.

Furthermore, the two companies completed a series of successful pilot scale tests throughout 2017. They completed the design, engineering and construction of the first production scale, 10 tonne per day E-Waste processing plant that was installed on-schedule and on-budget at the Memphis, Tennessee facility.

EnviroLeach Technologies, Inc. (EVLLF), closed Thursday's trading session at $0.8987, up 4.50%, on 17,150 volume with 19 trades. The average volume for the last 60 days is 28,647 and the stock's 52-week low/high is $0.246/$1.8554.

chart

StartMonday Technology Corp. (STMDF)

Dividend Investor, Science of Stocks, Investorx, OTC Markets, Stockhouse, MarketWatch, Barchart, GuruFocus, and Penny Stock Hub reported on StartMonday Technology Corp. (STMDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

StartMonday Technology Corp. engages in candidate selection solutions for employers in the retail and hospitality sectors. The Company helps employers select better candidates, faster, with the power of 15-second video introductions. A smart recruitment technology company, StartMonday Technology is based in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

StartMonday Technology’s dedication is to building strong tools for the Mobile Generation. In addition, the Company is further developing its technology with an open blockchain solution for verifiable career histories called CareerChain.

StartMonday's video-led mobile and web applications deliver a better impression of customer skills and personality, ultimately helping employers in deciding which candidates they should talk to first. This makes the process very efficient.

The Company’s core products center around 15-second videos filmed by candidates on their own mobile phones and web browsers. This puts job applications decisively in the social media and mobile native space.

This enables job seekers to present themselves in their own way. In addition to reducing cost and time-to-hire, StartMonday brings significant employer branding opportunities to its clients.

StartMonday Technology has partnered with Manhattan-based Talent Tech Labs (TTL) as part of their late-stage accelerator program aimed at advancing select, mature startups ready for targeted penetration into the North American market. Talent Tech Labs is a sector leader in the knowledge and analysis of up-and-coming trends and technologies applied to improving the state-of-the-art of recruitment.

Recently, StartMonday Technology announced plans for the commercial release of CareerChain. This is a blockchain technology solution for the human resource sector that is completing a meticulous and extensive phased developmental process in preparation for an approaching product launch. The Company has been developing CareerChain as a new brand asset and blockchain solution expressly for the job market.

CareerChain will be the first open, public standard for sharing career histories. Job seekers will create a CareerChain profile. They then use the profile to apply for jobs with one click; just enter once, and apply everywhere.

StartMonday Technology Corp. (STMDF), closed Thursday's trading session at $0.12, up 5.79%, on 2,030 volume with 3 trades. The average volume for the last 60 days is 23,883 and the stock's 52-week low/high is $0.1035/$0.5005.

chart

Impala Platinum Holdings Limited (IMPUY)

Zacks, YCharts, OTC Markets, Equity Clock, MarketWatch, GuruFocus, Marketbeat, Investopedia, and The Street reported on Impala Platinum Holdings Limited (IMPUY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Impala Platinum Holdings Limited is a top producer of platinum and associated platinum group metals (PGMs). The Company is structured around five mining operations and Implats Refining Services, which is a toll refining business. Its operations are located on the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. The Company is Implats Platinum Limited’s 96 percent-owned main operational unit. Impala Platinum Holdings is based in Johannesburg, South Africa.

The Company operates through Mining Operations, Refining Services, Chrome Processing, and Other segments. Impala Platinum Holdings produces platinum, palladium, rhodium, as well as nickel.

Impala Platinum has operations on the western limb of the world-renowned Bushveld Complex close to Rustenburg, South Africa. This operation consists of a 13 shaft mining complex and concentrating and smelting plants. The base and precious metal refineries are in Springs, east of Johannesburg.

Impala Platinum Holdings announced at the beginning of March 2018 that it delivered an improved performance at most operations for the half year ended December 31, 2017. It reported a Gross Profit of R733 million for the period, in comparison to a Gross Loss of R139 million for the prior comparable period.

Impala’s improved operating performance resulted primarily from efficiencies at Impala Rustenburg, a strong operational turnaround at Marula, and a sustained performance from Zimplats. This resulted in an improved headline Loss per Share of 21 cents. This is a 70.4 percent improvement over the previous period.

Recently, Implats’ Rustenburg operations, Impala Platinum, in partnership with the North West Department of Education and Sports Development and the Impala Bafokeng Trust (IBT) officially opened three schools at a celebratory event in Rustenburg.

At the official opening event, Mr. Mark Munroe, Chief Executive of Impala Platinum, said, “Given the challenging social context of our country, we are firmly committed to investing in sustainable development initiatives in the communities that are home to our employees and their families. Our investment in housing and educational projects demonstrates our commitment to developing viable communities that can live close to work but also have access to high-quality facilities such as schools and health centers.”

Implats has informed of developments concerning the Government of Zimbabwe’s intention to compulsorily acquire land measuring 27,948 hectares within its subsidiary Zimplats’ special mining lease area. Implats advised that Zimplats has agreed to release to the Government land measuring 23,903 hectares within Zimplats’ mining lease area in support of the Government’s efforts to enable participation by other investors in the platinum mining industry in Zimbabwe. Following this release of ground, Zimplats now holds two separate and non-contiguous pieces of land measuring in total 24,632 hectares.

Impala Platinum Holdings Limited (IMPUY), closed Thursday's trading session at $1.71, even for the day, on 9,200 volume with 10 trades. The average volume for the last 60 days is 70,353 and the stock's 52-week low/high is $1.46/$3.29.

chart

Nutra Pharma Corp. (NPHC)

Serious Traders, UndiscoveredEquities, Wallstreetlivechat, Innovative Marketing, StocksToBuyNow, PennyStocks24, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, Pumps and Dumps, and Winston Small Cap reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. The Company is marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market. Nutra Pharma has its head office in Coral Springs, Florida.

The Company, through its subsidiaries, carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are founded on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra. Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN.

In addition, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.

Nutra Pharma’s subsidiary, Designer Diagnostics, engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nutra Pharma has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Luxury Feet is specifically marketed for the treatment and prevention of pain and discomfort that women experience from wearing high heels.

Another is Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Furthermore, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.

The Company’s MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Its RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

Recently, Nutra Pharma announced that it filed a new provisional patent to protect its intellectual property (IP) surrounding its development of a drug to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease).

Rik J Deitsch, Nutra Pharma’s Chief Executive Officer, said, "Our primary drug for the treatment of Multiple Sclerosis is RPI-78M. This drug had been used in previous trials for the treatment of ALS with varying results. We now believe that we have discovered the modifications that are necessary to allow RPI-78M to work effectively against ALS progression.”

Nutra Pharma Corp. (NPHC), closed Thursday's trading session at $0.0017, up 21.43%, on 18,563,240 volume with 65 trades. The average volume for the last 60 days is 18,065,075 and the stock's 52-week low/high is $0.0004/$0.0069.

chart

Deer Horn Capital, Inc. (GODYF)

Speculating Stocks, CentralCharts, Stockwatch, OTC Markets, MarketWatch, Stockhouse, InvestorsHangout, InsiderTracking, Wallstreet Online, Northern Miner, Investing News Alerts, and HighRisingStocks reported on Deer Horn Capital, Inc. (GODYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Deer Horn Capital, Inc. engages in the acquisition, exploration, and evaluation of mineral properties. The Company’s vision is to develop Canada’s first silver-gold-tellurium (Ag-Au-Te) mine at the Deer Horn Project in north-central British Columbia. The Deer Horn Property has been recognized by First Solar, Inc. as one of the world's top four primary tellurium properties. Deer Horn Capital has its corporate headquarters in Delta, British Columbia.

The Company’s business strategy is to grow Deer Horn through partnering with industry leaders in “critical” or “green" minor metals extraction, manufacturing, supply and research and also with relevant governmental and educational institutions. Deer Horn’s vision is also to develop the Deer Horn Property’s other mineralized zones, which contain tungsten, copper, bismuth, lead, zinc and molybdenum.

The Company will develop the Deer Horn Project as a small-scale mine with a minimal environmental footprint and First Nations sanction and participation. The Project is in north-central British Columbia, 36 km south of the prolific Huckleberry Cu-Mo mine. The Project size is 5,133 ha (51.33 sq km) and its status is advanced exploration.

The Deer Horn Project has an NI 43-101 (National Instrument 43-101) compliant tellurium resource. The Project consists of gold & silver with high tellurium grades. Tellurium is classified as a “critical” or “green minor” metal. Tellurium represents one of earth’s rarest elements. Along with silver, it is a key constituent in the manufacture of solar panels.

At the Deer Horn Project, significant upside is in tungsten and copper porphyry potential. Exploration so far has outlined a number of important mineral zones across 2.4 kilometers. These remain open for expansion in three directions.

Yesterday, Deer Horn Capital reported positive results from an independent Preliminary Economic Assessment (PEA) at its Deer Horn gold-silver-tellurium polymetallic property in north-central British Columbia. The full PEA was prepared in accordance with National Instrument 43-101 regulations. The PEA recommended infill and tightly-spaced step-out diamond drilling centered on upgrading and expanding the existing high-grade resource.

Mr. Tyrone Docherty, Deer Horn Capital’s President and Chief Executive Officer, said, “We’ve engineered Deer Horn for low capital costs and rapid payback in a well-established mining jurisdiction. Our strategy is to put the project into production quickly and establish its viability initially on a small scale. Since the PEA was calculated on only 450 meters of a 2.4-kilometer-long mineralized system, we believe we can explore and expand the operation over time using mining cash flow and exploit the knowledge of the system that we gain as we mine.”

Deer Horn Capital, Inc. (GODYF), closed Thursday's trading session at $0.2909, even for the day. The average volume for the last 60 days is 327 and the stock's 52-week low/high is $0.025/$0.2909.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, Wallet Investor, InvestorsHangout, Stockhouse, Barchart, The Street, InvestorsHub, Business Insider, InvestingNews, Cannabis Newswire, ResearchPool, 4-Traders, MidasLetter, Daily Marijuana Observer, Weed Newswire, PrimedEquities, Marketwired, and TradingView reported on Beleave, Inc. (BLEVF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Additionally, it has patient services clinics operating throughout Ontario under the Medi-Green brand. The Company's wholly-owned subsidiary is Beleave Kannabis Corp. (previously First Access Medical, Inc.). Beleave lists on the OTCQX.

The Company’s goal is to provide a consistent, reliable and standardized product to suit the requirements of every person. Beleave has decades of growing experience coupled with industry leading equipment.

The Company focuses on green initiatives. Beleave grows its plants using no pesticides. Moreover, its facilities host a large-scale, commercial, solar installation that considerably offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

The Company’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

Last month, Beleave announced that its wholly-owned subsidiary, Beleave Kannabis Corp., received its approval and provider number to service those who have qualified for cannabis coverage via Medavie Blue Cross. This includes the Canadian veteran community.

Medavie Blue Cross is one of Canada's foremost Blue Cross plans. Cannabis coverage is available to patients approved by Blue Cross. Medavie Blue Cross has more than 1,000,000 card holders. Medavie is a non-profit Canadian Medical care insurance company based in Moncton, New Brunswick.

In addition, in May, Beleave announced that it added another location to its network of Medical Cannabis Clinics. The new location is located at 211 Dundas Street in London, Ontario. The expectation is that it will open soon.

Beleave recently closed on the acquisition of the Medi-Green Cannabis Clinic Network.  London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Perth, Kingston, and Hamilton.

This week, Beleave announced that it was selected to operate one of Saskatchewan's forthcoming cannabis retail stores. Beleave was selected through a two phase Request for Proposal (RFP) process that started in March. Cannabis retail stores in the Province of Saskatchewan must be standalone operations, selling only cannabis, cannabis accessories and ancillary items as defined by Saskatchewan Liquor and Gaming Authority (SLGA).

Beleave, Inc. (BLEVF), closed Thursday's trading session at $1.3011, down 2.75%, on 92,989 volume with 130 trades. The average volume for the last 60 days is 90,808 and the stock's 52-week low/high is $0.823/$2.80.

chart

Alacer Gold Corp. (ALIAF)

MarketWatch, TradingView, Investing, Silverstocker, InvestorPlace, GoldStockData, NorthernMiner, 4-Traders, Investopedia, OTC Markets, The Street, MiningFeeds, Information Vine, and Penny Stock Tweets reported on Alacer Gold Corp. (ALIAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alacer Gold Corp. is a foremost intermediate gold mining company headquartered in Denver, Colorado. The Company has an 80 percent interest in the world-class Çöpler Gold Mine in Turkey operated by Anagold Madencilik Sanayi ve Ticaret A.S. The remaining 20 percent is owned by Lidya Madencilik Sanayi ve Ticaret A.S. Alacer Gold is pursuing initiatives to enhance value beyond the present mine plan. Alacer Gold’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s main emphasis is to take advantage of its cornerstone Çöpler Mine and strong balance sheet to maximize portfolio value, maximize free cash flow, and minimize project risk. The Çöpler Mine is located in east-central Turkey in the Erzincan Province.

The Çöpler Gold Mine produced 119,036 ounces of gold during 2016. Çöpler has considerable Probable Reserves of 4 million recoverable ounces and Measured and Indicated Resources of 6 million ounces of contained gold. These provide the basis for Çöpler’s 20 year mine life.

At present, the Mine is an open-pit, heap-leach operation producing low-cost gold from oxide ore. Over the life of the present heap-leach project, roughly 76 percent of the gold contained in the oxide ore is expected to be recovered.

In May of 2016, Alacer Gold’s Board of Directors approved full construction of the Sulfide Project at the Çöpler Gold Mine, with first gold pour expected in Q3 of 2018. The Çöpler orebody contains refractory sulfide ore. This necessitates a different processing solution than heap-leaching to extract the gold.

The Sulfide Project construction is over 75 percent complete, under budget, and on course for first gold production in Q3 2018. The expectation is that the Sulfide Project will deliver long-term growth with strong financial returns and adds 20 years of production at the Çöpler Gold Mine. The Sulfide Project will bring Çöpler’s remaining life-of-mine gold production to greater than 2 million ounces at All-in Sustaining Costs averaging $645 per ounce.

This week, Alacer Gold announced full-year 2017 production results, unaudited full-year cost results, and 2018 production and cost guidance.

Mr. Rod Antal, President and Chief Executive Officer of Alacer Gold, stated, “I am pleased to report that we produced 168,1631 ounces of gold at unaudited All-in Sustaining Costs (AISC) of $685 per ounce in 2017, meeting our original production and beating AISC cost guidance for the year. The production initiatives generated through our operational excellence program were very successful, delivering 64,542 ounces in the fourth quarter, making it the strongest quarter of the year… 2018 production guidance is 120,000 to 190,000 ounces from Çöpler oxides and sulfides. We also expect initial mining at a new oxide deposit, Çakmaktepe, later this year.”

Alacer Gold Corp. (ALIAF), closed Thursday's trading session at $1.84, up 0.58%, on 2,225 volume with 6 trades. The average volume for the last 60 days is 22,697 and the stock's 52-week low/high is $1.53/$2.00.

chart

MYM Nutraceuticals, Inc. (MYMMF)

OTC Markets, Barchart, Investing.com, Stockhouse, MarketWatch, InvestorsHub, and Market News Updates reported on MYM Nutraceuticals, Inc. (MYMMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MYM Nutraceuticals, Inc. concentrates on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. The OTCQB-listed Company is looking to acquire complementary businesses and assets in the technology, nutraceuticals, as well as CBD sectors. MYM is the sole owner of CBD brands HempMed, Joshua Tree, and Dr. Furbaby. MYM Nutraceuticals has its corporate office in Vancouver, British Columbia.

HempMed is targeted at the dispensary market. Joshua Tree is targeted for the mainstream health market. Dr. Furbaby is the Company’s CBD line of products specifically for pets.

MYM Nutraceuticals is currently building three large-scale production facilities in Canada and Australia. These are the Northern Rivers Project; the Weedon Project; and the Laval Project. Upon completion, the total amount of greenhouse growing space will be greater than 2.7 million square feet.

The Weedon Project is in Weedon, Quebec. The Project will include a cannabis museum and a cannabis university for industry training. The Weedon Project has 1.5 million sq. ft. of greenhouse. The Company received approval and commenced Phase One construction of the Weedon production facility.

The Laval Project facility (Laval, Quebec) is 10,000 sq. ft. It will undergo expansion to 26,000 sq. ft. by 2019. The estimation is that the Laval Project will produce sales of $20 million by 2019.

The Northern Rivers Project (Casino, New South Wales, Australia) is a 1.2 million sq. ft. greenhouse project. The first crop is expected to be planted in Q4 2018. The Northern Rivers Project facility is believed to be the Southern Hemisphere's largest purpose-built greenhouse, designed specifically to produce medical-grade cannabis.

MYM Nutraceuticals also has its MJT Manufacturing Project (Toronto, Ontario). The 5,000 sq. ft. production facility is a GMP (Good Manufacturing Practice) certified, state-of-the-art extraction lab and production facility dedicated to industrial hemp processing (CBD).

In May, MYM Nutraceuticals announced that it acquired an additional 18 percent of CannaCanada and the Weedon, Quebec project from 9292-4372 Quebec, Inc., bringing its total ownership of the late stage ACMPR applicant, up to 93 percent. Construction of the Weedon facility is now taking place with the first set of greenhouses due to be completed and ready for Health Canada's final review in Q3 2018.

At the end of May, MYM Nutraceuticals announced the hiring of Mr. Joel Lalancette as Master Grower at MYM’s 1.5 million square foot medicinal cannabis greenhouse facility, now under construction in Weedon. Mr. Lalancette has 13 years of experience in the greenhouse industry. He is an integrated operator who has been a leader in establishing manifold greenhouse businesses.

This week, MYM Nutraceuticals announced that through its partially owned subsidiaries it finalized the purchase of 329 acres in the township of Weedon, Quebec to construct its 1.5 million square foot state-of-the-art medicinal cannabis greenhouse facility. The 329 acres of land, presently under construction, was purchased for $660,000.

MYM Nutraceuticals, Inc. (MYMMF), closed Thursday's trading session at $1.33, up 5.56%, on 481,127 volume with 559 trades. The average volume for the last 60 days is 250,189 and the stock's 52-week low/high is $0.198/$4.00.

chart

Bearing Lithium Corp. (BRGRF)

MarketWatch, TradingView, and InvestorsHub reported on Bearing Lithium Corp. (BRGRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bearing Lithium Corp. is a mineral exploration and development company concentrating mainly on lithium. Through an agreement with Li3 Energy, Inc. (LIEG), Bearing Lithium will acquire an undivided 17.7 percent interest in the advanced-stage Maricunga lithium brine project in Chile. This represents one of the highest-grade development opportunities in the Americas. Bearing Lithium is headquartered in Vancouver, British Columbia. The Company lists on the OTCQB.

Bearing Lithium’s other projects include Fish Lake Valley and the HY/Jay project. The Fish Lake Valley Lithium property is in Esmeralda County, Nevada. It consists of a contiguous 1,620-acre package of 81 lode claims.

The HY/Jay project is in the Upper Hyland River region of eastern Yukon. It is in a belt that hosts a number of high-grade gold vein occurrences. This includes the 3Ace property now undergoing exploration by Golden Predator Mining Corp. In 2011, the HY claim group was subsequently expanded by the addition of the Jay claims via staking.

Bearing Lithium entered into a definitive agreement to acquire Li3 Energy and its interest in the Maricunga Project. Currently, Li3 holds the 17.7 percent interest in the Maricunga Project along with Minera Salar Blanco (MSB) and Lithium Power International Limited at 32.3 percent and 50 percent respectively pursuant to the Joint Venture (JV) arrangement.

Recently, Bearing Lithium reported that a second sample of lithium carbonate with a purity of 99.9 percent was produced by Veolia Water Technologies using concentrated brine from the Maricunga project. This is a succeeding sample to the earlier release on February 21, 2018 that announced a 99.4 percent purity lithium carbonate sample produced by GEA. The Maricunga JV continues to advance towards the completion of a Definitive Feasibility Study (DFS) expected in Q3 2018.

Last week, Bearing Lithium provided an update on its spin-out transaction. The Company signed an Arrangement Agreement with its wholly-owned subsidiary Lions Bay Mining Corp. (SpinCo).  Under the terms of the Arrangement Agreement, Bearing Lithium will transfer its interests in exploration projects in the gold district of the Yukon and a lithium project in Nevada (the Exploration Projects) in exchange for 5,510,000 common shares of SpinCo (the Consideration Shares).

Bearing Lithium will retain 2,755,000 Consideration Shares and will spin out 2,755,000 Consideration Shares (the Spin-Out Shares) to Bearing Lithium shareholders.  Therefore, the anticipation is that that each Bearing shareholder will receive 0.049921 of a Spin-Out Share for each Bearing common share held.  Bearing Lithium will continue to hold shares of Commander Resources Ltd. and its interest in the Maricunga lithium project.

Bearing Lithium Corp. (BRGRF), closed Thursday's trading session at $0.20, even for the day, on 66,575 volume with 7 trades. The average volume for the last 60 days is 21,615 and the stock's 52-week low/high is $0.1991/$0.805.

chart

Mentor Capital, Inc. (MNTR)

Market Intelligence Center Alert, StreetAuthority Daily, Promotion Stock Secrets, InvestorsUnderground, Cancer Roll Up Strategy, Stockgoodies, Laissez Faire Today, BUYINS.NET, Stocks That Move, Wealth Insider Alert, Five Star Stock Picks, and Stock Profile reported previously on Mentor Capital, Inc. (MNTR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. The Company looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial goals, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital is based in San Diego, California.

Mentor participates in the legal recreational marijuana market. Nonetheless, the Company’s favored emphasis is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, lessening ocular pressures from glaucoma, in addition to blunting chronic pain.

The Company takes a major position in the varied members of its portfolio of participating companies. However, it leaves operating control in the hands of the cannabis company founders.

Mentor Capital’s preferred involvement is with larger and private pre-IPO (Initial Public Offering) medical marijuana companies, which it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity.

The Company transferred to the cannabis space from front-line cancer investments It still keeps only minor cancer investments. Mentor will complete the shift to the cannabis market as profitable opportunities to exit present themselves.

In March of 2017, Mentor announced that it took a $1.0 million position in the stock of GW Pharmaceuticals, Plc (GWPH). GW Pharmaceuticals is a United Kingdom (UK) based group developing a family of cannabinoid prescription medicines.

In April 2017, Mentor Capital announced that it initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. It will provide financing and business management for any commercial development and holds an 80 percent interest. Dr. Robert M. Mandelkorn holds 20 percent. In addition, he provides the medical leadership for this venture. Dr. Mandelkorn is an ophthalmologist specializing in glaucoma.

Last month, Mentor Capital announced that during January it funded an additional $900,000 into G FarmaLabs. This brings the ten month multi-investment total by Mentor into G Farma to $1.8 million, which is in addition to an earlier and separate $600,000 stock transaction.

G Farma Founder, Ata Gonzalez, said, “With Mentor’s financial support, G Farma is now expanding its extraction and bottling business to conquer the California adult use market. We have a great relationship with Mentor Capital’s executive team and I am honored that they have chosen again and again to ensure our growing brand has been and continues to be well-funded as we move into the exciting cannabis future.”

Today, Mentor Capital announced that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor Capital stated it would be pleased to make a series of cannabis centered investments with cannabis veteran and Pueblo Founder, Pat Leonard.  Mentor has set up Mentor Partner II, LLC as a channel for this purpose. The initial investment is roughly $400,000 lease of a system for supercritical extraction.

Mentor Capital, Inc. (MNTR), closed Thursday's trading session at $1.03, up 3.99%, on 77,398 volume with 101 trades. The average volume for the last 60 days is 73,385 and the stock's 52-week low/high is $0.45/$2.65.

chart

The QualityStocks Company Corner

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; Frankfurt: A2DYWC) (“Petroteq” or the “Company”) was pleased to announce today that it has acquired additional acreage in the resource rich Uintah Basin. Also today, NetworkNewsWire released a report on the company detailing how PQEFF is fueling rising expectations regarding its resource potential, as its oil sands extraction project in Utah continues to evolve.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.9191, up 19.99%, on 225,401 volume with 137 trades. The average volume for the last 60 days is 121,633 and the stock's 52-week low/high is $0.2395/$1.8892.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (REFG), a Nevada corporation specializing in state-of-the-art financial services structured to serve the medical cannabis and banking industries, announced that its subsidiary, SpeedyGrow, was featured on KREX’s news story about CBD and hemp.  KREX is the CBS-affiliated television station in Grand Junction, Colorado. The news segment may be viewed at this link: http://www.westernslopenow.com/news/local-news/special-report-hemp-the-grand-valley-s-new-cash-crop-/1194907015.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0465, up 4.49%, on 618,793 volume with 82 trades. The average volume for the last 60 days is 576,934 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

The cannabis industry is about more than medicine and recreational drugs. Whether selling hemp-derived textile and construction products or providing resources to support cannabis growers, companies are now accessing the market in a variety of ways. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is developing hemp-based wellness products and cultivating industrial hemp on a large scale in Canada and the United States.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0483, up 5.00%, on 9,246,065 volume with 635 trades. The average volume for the last 60 days is 5,428,261 and the stock's 52-week low/high is $0.0188/$0.0728.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Lithium Producers Expand Amid Market Supply Squeeze," featuring Lithium Chile Inc. (TSXV: LITH) (OTCQB: LTMCF). To hear the NetworkNewsAudio version, visit http://nnw.fm/2M5Jg. To read the original editorial, visit http://nnw.fm/0Hfpa. Also today, NetworkNewsWire released a report on the company detailing how LTMCF stands ready to meet the EV market’s concerns about future lithium supply. Additionally, LTMCF was featured in an article on lithium being the oil of the 21st century.

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.7676, off by 0.84%, on 122,225 volume with 101 trades. The average volume for the last 60 days is 5,284 and the stock's 52-week low/high is $0.6587/$0.9021.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

With recent fatal accidents fresh in the public mind involving cars equipped with driver-assistance technology, Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) is pressing on with a unique obstacle-detection vision system that raises the safety standard higher than ever. In an audio press release on May 24 (http://nnw.fm/A0nJi), Foresight said that its QuadSight™ system promises key advantages over other detection systems currently at various stages of development for use in self-driving cars. In tests, QuadSight’s™ sensors achieved close to 100 percent detection of obstacles.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.83, off by 0.67%, on 75,025 volume with 108 trades. The average volume for the last 60 days is 24,390 and the stock's 52-week low/high is $2.44/$11.70.

Recent News

chart

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based resource company QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) recently provided results of historical assays regarding its Irgon Lithium Mine Project. An article further discussing the report reads: “QMC recently announced the release of results of historical assays conducted by the Lithium Corporation of Canada (LCOC) (http://nnw.fm/aKu1X). Also today, NetworkNewsWire released a report on the company detailing how QMCQF is optimistic about the potentially large resources to which it holds access at the Irgon Lithium Mine Project in Manitoba.

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.42, up 0.17%, on 69,290 volume with 39 trades. The average volume for the last 60 days is 138,647 and the stock's 52-week low/high is $0.0748/$1.46.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, is pleased to share updates on its ongoing CBD formula patents and medical device progress. Also today, CannabisNewsWire released a report on the company detailing how ETST has been networking and spreading brand awareness across four cannabis expos held in Canada and the United States, including the Toronto Lift & Co. Expo, CannXperience, the Florida Medical Cannabis Conference & Exhibition and the Cannabis World Congress & Business Expo.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.709, off by 0.14%, on 2,210 volume with 6 trades. The average volume for the last 60 days is 14,758 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the results of its annual general and special meeting of shareholders held on June 5, 2018 (the “Meeting”).

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” ABcann Global CEO Barry Fishman said.

ABcann Global owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

ABcann has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by ABcann’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting ABcann’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

ABcann’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with ABcann’s philosophy of quality and innovation.

ABcann’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, ABcann also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

ABcann Global (ABCCF), closed the day's trading session at $1.21, off by 0.82%, on 442,809 volume with 350 trades. The average volume for the last 60 days is 260,155 and the stock's 52-week low/high is $0.65/$3.2929.

Recent News

chart

BLOCKStrain Technology Corp. (TSXV: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

BLOCKSTRAIN TECHNOLOGY CORP. (TSXV: DNAX) (the "Company" or "BLOCKStrain") is pleased to announce that cannabis pioneer Derek Pedro has agreed to join the Company's Advisory Board.

BLOCKStrain Technology Corp. (TSX.V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.90, off by 5.26%, on 1,003,000 volume. The stock's 52-week low/high is $0.10/$1.20.

Recent News

chart

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Cobalt on Critical List as US Moves toward Mineral Independence," featuring First Cobalt Corp. (TSXV: FCC) (OTCQX: FTSSF). To hear the NetworkNewsAudio version, visit http://nnw.fm/5K9Uh. To read the original editorial, visit http://nnw.fm/Mc3DW.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.55156, off by 5.13%, on 431,847 volume with 120 trades. The average volume for the last 60 days is 129,580 and the stock's 52-week low/high is $0.375/$1.3041.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.